These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Biancofiore G, Bindi ML, Baldassarri R, Romanelli AM, Catalano G, Filipponi F, Vagelli A, Mosca F. Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510 [Abstract] [Full Text] [Related]
4. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation. Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH. Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954 [Abstract] [Full Text] [Related]
11. High cure rate of invasive fungal infections in immunocompromised children using ambisome. Ringdén O, Tollemar J, Dahllöf G, Tydén G. Transplant Proc; 1994 Feb; 26(1):175-7. PubMed ID: 8108927 [No Abstract] [Full Text] [Related]
13. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation. Ringdén O, Andström EE, Remberger M, Dahllöf G, Svahn BM, Tollemar J. Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772 [Abstract] [Full Text] [Related]
14. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Badiee P, Kordbacheh P, Alborzi A, Malekhoseini S, Zeini F, Mirhendi H, Mahmoodi M. Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362 [Abstract] [Full Text] [Related]
15. Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation. Roman E, Osunkwo I, Militano O, Cooney E, van de Ven C, Cairo MS. Pediatr Blood Cancer; 2008 Feb; 50(2):325-30. PubMed ID: 17514732 [Abstract] [Full Text] [Related]